CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,082,000 | +12.8% | 2,295,272 | 0.0% | 0.15% | -11.6% |
| Q4 2018 | $5,394,000 | -46.6% | 2,295,272 | 0.0% | 0.17% | -35.2% |
| Q3 2018 | $10,099,000 | -15.4% | 2,295,272 | 0.0% | 0.27% | -22.6% |
| Q2 2018 | $11,935,000 | +30.0% | 2,295,272 | 0.0% | 0.34% | +35.8% |
| Q1 2018 | $9,181,000 | -41.2% | 2,295,272 | 0.0% | 0.25% | -42.3% |
| Q4 2017 | $15,608,000 | +44.3% | 2,295,272 | +71.9% | 0.44% | +47.2% |
| Q3 2017 | $10,816,000 | +30.8% | 1,335,272 | +21.1% | 0.30% | +18.2% |
| Q2 2017 | $8,269,000 | +1.6% | 1,102,578 | +5.6% | 0.25% | -4.9% |
| Q1 2017 | $8,142,000 | -25.0% | 1,043,824 | 0.0% | 0.27% | -33.8% |
| Q4 2016 | $10,856,000 | +27.0% | 1,043,824 | +39.8% | 0.40% | +33.6% |
| Q3 2016 | $8,551,000 | +11.1% | 746,824 | 0.0% | 0.30% | -1.0% |
| Q2 2016 | $7,700,000 | -18.8% | 746,824 | 0.0% | 0.30% | -19.4% |
| Q1 2016 | $9,485,000 | +18.4% | 746,824 | +60.0% | 0.38% | +66.8% |
| Q4 2015 | $8,008,000 | – | 466,679 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |